These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis. Chong LY; Head K; Hopkins C; Philpott C; Schilder AG; Burton MJ Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011996. PubMed ID: 27115217 [TBL] [Abstract][Full Text] [Related]
17. A clinical trial of ipratropium bromide nasal spray in patients with perennial nonallergic rhinitis. Bronsky EA; Druce H; Findlay SR; Hampel FC; Kaiser H; Ratner P; Valentine MD; Wood CC J Allergy Clin Immunol; 1995 May; 95(5 Pt 2):1117-22. PubMed ID: 7751528 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of topical combinations of ipratropium and xylometazoline for the treatment of symptoms of runny nose and nasal congestion associated with acute upper respiratory tract infection. Eccles R; Pedersen A; Regberg D; Tulento H; Borum P; Stjärne P Am J Rhinol; 2007; 21(1):40-5. PubMed ID: 17283559 [TBL] [Abstract][Full Text] [Related]
19. The anticholinergic agent, ipratropium bromide, is useful in the treatment of rhinorrhea associated with perennial allergic rhinitis. Kaiser HB; Findlay SR; Georgitis JW; Grossman J; Ratner PH; Tinkelman DG; Wood CC Allergy Asthma Proc; 1998; 19(1):23-9. PubMed ID: 9532321 [TBL] [Abstract][Full Text] [Related]
20. Use of 0.06% ipratropium bromide nasal spray in children aged 2 to 5 years with rhinorrhea due to a common cold or allergies. Kim KT; Kerwin E; Landwehr L; Bernstein JA; Bruner D; Harris D; Drda K; Wanger J; Wood CC; Ann Allergy Asthma Immunol; 2005 Jan; 94(1):73-9. PubMed ID: 15702820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]